Texas Biomed Files Patent Application for Novel HIV Vaccine
November 20, 2012
The Texas Biomedical Research Institute (Texas Biomed) has applied for a patent for a genetically-engineered vaccine for HIV prevention. The vaccine is designed to be administered in a single dose that will last the patient a lifetime. It targets the outer layers of the body structures that first come into contact with the virus. Officials at Texas Biomed believe that the vaccine could be adapted for use against other infections.
San Antonio Business Journal
11.19.2012; W. Scott Bailey
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)